Inventor · disambiguated record
Jean-Francois Zagury
Also filed as: ZAGURY JEAN-FRANCOIS · ZAGURY Jean-François
24 granted patents·8 pending applications·174 citations·filing 1992–2021
95Inventor score
Top patents by PatentIndex Score
32 records- 0188US7892558B2Isolated TNF-alpha peptide and pharmaceutical composition thereofVAXCONSULTING·Filed 2005·Granted Feb 22, 2011·12 cites·7 claims
- 0287US6200575B1Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising themNEOVACS·Filed 2000·Granted Mar 13, 2001·18 cites·28 claims
- 0384US7022482B2Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal usesNEOVACS·Filed 2003·Granted Apr 4, 2006·14 cites·15 claims
- 0481US6093405AInactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokinesNEOVACS·Filed 1992·Granted Jul 25, 2000·55 cites·12 claims
- 0578US6878370B1Chemically modified TNF-αNEOVACS·Filed 2000·Granted Apr 12, 2005·7 cites·7 claims
- 0677US7022326B1Carboxymethylated retroviral regulatory proteins and interferon-αNEOVACS·Filed 2000·Granted Apr 4, 2006·9 cites·10 claims
- 0770US7892529B2Peptides for active anti-cytokine immunizationVAXCONSULTING·Filed 2009·Granted Feb 22, 2011·0 cites·7 claims
- 0869US8975399B2Benzenesulfon amide-compound treatment of a pathological condition linked to an excessive effect of TNFZAGURY JEAN-FRANCOIS·Filed 2011·Granted Mar 10, 2015·5 cites·13 claims
- 0969US6132721ANon-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing sameNEOVACS·Filed 1996·Granted Oct 17, 2000·20 cites·27 claims
- 1066US8101165B2Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factorsZAGURY JEAN FRANCOIS·Filed 2007·Granted Jan 24, 2012·0 cites·4 claims
- 1166US7641895B2Peptides for active anti-cytokine immunizationVAXCONSULTING·Filed 2008·Granted Jan 5, 2010·0 cites·4 claims
- 1264US9669077B2Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6DESALLAIS LUCILLE·Filed 2012·Granted Jun 6, 2017·3 cites·8 claims
- 1364US7393523B2Peptides for active anti-cytokine immunizationVAXCONSULTING·Filed 2003·Granted Jul 1, 2008·1 cites·4 claims
- 1462US8529881B2Peptides for active anti-cytokine immunizationZAGURY JEAN-FRANCOIS·Filed 2012·Granted Sep 10, 2013·0 cites·9 claims
- 1562US6455045B1Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing themNEOVACS·Filed 1999·Granted Sep 24, 2002·13 cites·11 claims
- 1661US6420141B1Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aidsNEOVACS·Filed 1998·Granted Jul 16, 2002·17 cites·15 claims
- 1760US8277792B2Peptides for active anti-cytokine immunizationZAGURY JEAN-FRANCOIS·Filed 2012·Granted Oct 2, 2012·0 cites·9 claims
- 1859US8147819B2Peptides for active anti-cytokine immunizationZAGURY JEAN-FRANCOIS·Filed 2011·Granted Apr 3, 2012·0 cites·14 claims
- 1956US7504479B2Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal usesNEOVACS·Filed 2005·Granted Mar 17, 2009·0 cites·14 claims
- 2051US2004028647A1Vaccines against cytokines and growth factors derived from malignant tumoursFiled 2001·Application pending·0 cites
- 2151US2023293636A1Pharmaceutical composition for the prevention or treatment of post-surgical painPEPTINOV·Filed 2020·Application pending·0 cites
- 2248US2004185058A1Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorderFiled 2002·Application pending·0 cites
- 2347US2023131650A1Immunogenic conjugate intended to induce an immune response directed against interleukin-6PEPTINOV·Filed 2020·Application pending·0 cites
- 2446US7208148B2Chemically modified cytokinesNEOVACS S A·Filed 2005·Granted Apr 24, 2007·0 cites·19 claims
- 2545US2006252075A1Method for monitoring anti-HIV treatment in HIV infected individualsNEOVACS·Filed 2006·Application pending·0 cites
- 2645US2023416239A1Compounds and methods for treating a cytokine-mediated diseaseCONSERVATOIRE NAT DES ARTS ET METIERS·Filed 2021·Application pending·0 cites
- 2741US10456456B2Anti-IL-6 vaccine compositionPEPTINOV SAS·Filed 2017·Granted Oct 29, 2019·0 cites·5 claims
- 2841US2004005330A1Mutated HIV TatFiled 2002·Application pending·0 cites
- 2940US2021371496A1Anti-pd-1 vaccine compositionPEPTINOV SAS·Filed 2019·Application pending·0 cites
- 3039US8632781B2Immunogenic compounds comprising peptides of IL1βZAGURY JEAN-FRANCOIS·Filed 2011·Granted Jan 21, 2014·0 cites·18 claims
- 3124US7067246B1Method for determining prognosis of HIV infected individualsNEOVACS S A·Filed 1999·Granted Jun 27, 2006·0 cites·2 claims
- 3223US9301997B2Method of vaccination for limiting articular inflammation in rheumatoid arthritis and multiple sclerosis by administering IL-23 peptidesZAGURY Jean-François·Filed 2010·Granted Apr 5, 2016·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Jean-Francois Zagury files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →